Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
Abstract Aims We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation‐based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. Methods In this prospect...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13404 |
id |
doaj-55af40f7e153483f8a72d7edbb88e7e4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jutta S. Swolinsky Niklas P. Nerger David M. Leistner Frank Edelmann Fabian Knebel Enkhtuvshin Tuvshinbat Caroline Lemke Robert Roehle Michael Haase Maria Rosa Costanzo Geraldine Rauch Veselin Mitrovic Edis Gasanin Daniel Meier Peter A. McCullough Kai‐Uwe Eckardt Bruce A. Molitoris Kai M. Schmidt‐Ott |
spellingShingle |
Jutta S. Swolinsky Niklas P. Nerger David M. Leistner Frank Edelmann Fabian Knebel Enkhtuvshin Tuvshinbat Caroline Lemke Robert Roehle Michael Haase Maria Rosa Costanzo Geraldine Rauch Veselin Mitrovic Edis Gasanin Daniel Meier Peter A. McCullough Kai‐Uwe Eckardt Bruce A. Molitoris Kai M. Schmidt‐Ott Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure ESC Heart Failure Acute heart failure Worsening kidney function Acute kidney injury CKD‐EPI formula Measured GFR Visible fluorescent injectate |
author_facet |
Jutta S. Swolinsky Niklas P. Nerger David M. Leistner Frank Edelmann Fabian Knebel Enkhtuvshin Tuvshinbat Caroline Lemke Robert Roehle Michael Haase Maria Rosa Costanzo Geraldine Rauch Veselin Mitrovic Edis Gasanin Daniel Meier Peter A. McCullough Kai‐Uwe Eckardt Bruce A. Molitoris Kai M. Schmidt‐Ott |
author_sort |
Jutta S. Swolinsky |
title |
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure |
title_short |
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure |
title_full |
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure |
title_fullStr |
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure |
title_full_unstemmed |
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure |
title_sort |
serum creatinine and cystatin c‐based estimates of glomerular filtration rate are misleading in acute heart failure |
publisher |
Wiley |
series |
ESC Heart Failure |
issn |
2055-5822 |
publishDate |
2021-08-01 |
description |
Abstract Aims We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation‐based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. Methods In this prospective cohort study of 50 hospitalized acute heart failure patients undergoing decongestive therapy, we applied an intravenous visible fluorescent injectate (VFI), consisting of a low molecular weight component to measure GFR and a high molecular weight component to correct for measured plasma volume. Thirty‐eight patients had two sequential GFR measurements 48 h apart. The co‐primary endpoints of the study were safety of VFI and plasma stability of the high molecular weight component. A key secondary endpoint was to compare changes in measured GFR (mGFR) to changes of serum creatinine, cystatin C and estimated GFR. Results VFI‐based GFR measurements were safe and consistent with plasma stability of the high molecular weight component and glomerular filtration of the low molecular weight component. Filtration marker‐based point estimates of GFR, when compared with mGFR, provided only moderate correlation (Pearson's r, range 0.80–0.88, depending on equation used), precision (r2, range 0.65–0.78) and accuracy (56%–74% of estimates scored within 30% of mGFR). Correlations of 48‐h changes GFR estimates and changes of mGFR were significant (P < 0.05) but weak (Pearson's r, range 0.35–0.39). Observed decreases of eGFR by more than 15% had a low sensitivity (range 38%–46%, depending on equation used) in detecting true worsening mGFR, defined by a >15% decrease in mGFR. Conclusions In patients hospitalized for acute heart failure, serum creatinine‐ and cystatin C‐based predictions performed poorly in detecting actual changes of GFR. These data challenge current clinical strategies to evaluate dynamics of kidney function in acute heart failure. |
topic |
Acute heart failure Worsening kidney function Acute kidney injury CKD‐EPI formula Measured GFR Visible fluorescent injectate |
url |
https://doi.org/10.1002/ehf2.13404 |
work_keys_str_mv |
AT juttasswolinsky serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT niklaspnerger serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT davidmleistner serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT frankedelmann serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT fabianknebel serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT enkhtuvshintuvshinbat serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT carolinelemke serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT robertroehle serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT michaelhaase serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT mariarosacostanzo serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT geraldinerauch serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT veselinmitrovic serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT edisgasanin serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT danielmeier serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT peteramccullough serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT kaiuweeckardt serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT bruceamolitoris serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure AT kaimschmidtott serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure |
_version_ |
1721265363371425792 |
spelling |
doaj-55af40f7e153483f8a72d7edbb88e7e42021-07-28T18:55:36ZengWileyESC Heart Failure2055-58222021-08-01843070308110.1002/ehf2.13404Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failureJutta S. Swolinsky0Niklas P. Nerger1David M. Leistner2Frank Edelmann3Fabian Knebel4Enkhtuvshin Tuvshinbat5Caroline Lemke6Robert Roehle7Michael Haase8Maria Rosa Costanzo9Geraldine Rauch10Veselin Mitrovic11Edis Gasanin12Daniel Meier13Peter A. McCullough14Kai‐Uwe Eckardt15Bruce A. Molitoris16Kai M. Schmidt‐Ott17Department of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyDepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyDepartment of Internal Medicine and Cardiology Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Campus Benjamin Franklin Berlin GermanyClinical Research Unit Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin GermanyDepartment of Cardiology and Angiology Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Campus Mitte Berlin GermanyDepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyDepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyClinical Research Unit Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin GermanyFaculty of Medicine Otto von‐Guericke‐University Magdeburg Magdeburg GermanyAdvocate Heart Institute Naperville IL USAClinical Research Unit Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin GermanyDepartment of Cardiology Kerckhoff Klinik Bad Nauheim GermanyDepartment of Cardiology Kerckhoff Klinik Bad Nauheim GermanyFAST BioMedical Indianapolis IN USABaylor University Medical Center, Baylor Heart and Vascular Hospital Baylor Heart and Vascular Institute Dallas TX USADepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanySchool of Medicine Indiana University Indianapolis IN USADepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyAbstract Aims We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation‐based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. Methods In this prospective cohort study of 50 hospitalized acute heart failure patients undergoing decongestive therapy, we applied an intravenous visible fluorescent injectate (VFI), consisting of a low molecular weight component to measure GFR and a high molecular weight component to correct for measured plasma volume. Thirty‐eight patients had two sequential GFR measurements 48 h apart. The co‐primary endpoints of the study were safety of VFI and plasma stability of the high molecular weight component. A key secondary endpoint was to compare changes in measured GFR (mGFR) to changes of serum creatinine, cystatin C and estimated GFR. Results VFI‐based GFR measurements were safe and consistent with plasma stability of the high molecular weight component and glomerular filtration of the low molecular weight component. Filtration marker‐based point estimates of GFR, when compared with mGFR, provided only moderate correlation (Pearson's r, range 0.80–0.88, depending on equation used), precision (r2, range 0.65–0.78) and accuracy (56%–74% of estimates scored within 30% of mGFR). Correlations of 48‐h changes GFR estimates and changes of mGFR were significant (P < 0.05) but weak (Pearson's r, range 0.35–0.39). Observed decreases of eGFR by more than 15% had a low sensitivity (range 38%–46%, depending on equation used) in detecting true worsening mGFR, defined by a >15% decrease in mGFR. Conclusions In patients hospitalized for acute heart failure, serum creatinine‐ and cystatin C‐based predictions performed poorly in detecting actual changes of GFR. These data challenge current clinical strategies to evaluate dynamics of kidney function in acute heart failure.https://doi.org/10.1002/ehf2.13404Acute heart failureWorsening kidney functionAcute kidney injuryCKD‐EPI formulaMeasured GFRVisible fluorescent injectate |